Mervat Elsadek¹, Nazik Abed² and Mohammed Al Abadie³*

¹ The Midlands Medical Academy, United Kingdom
²HealthHarmonie and The Midlands Medical Academy, United Kingdom
³Clinical Director and Consultant Dermatologist, North Cumbria Integrated Care NHS Foundation Trust, UCLAN Medical School, United Kingdom

*Corresponding Author: Mohammed Al Abadie, Professor, Clinical Director and Consultant Dermatologist, North Cumbria Integrated Care NHS Foundation Trust, UCLAN Medical School, United Kingdom.

Received: October 08, 2024; Published: December 31, 2024

Abstract

This review explores the multifaceted applications of mesotherapy in dermatology, focusing on its effectiveness in treating localised pain, promoting skin rejuvenation, addressing hyperpigmentation, and stimulating hair growth. Mesotherapy, a minimally invasive technique involving targeted injections of therapeutic agents, offers promising results by enhancing the residence time of medica tions in the affected areas. Studies indicate its positive impact on skin hydration, firmness, and elasticity. Specifically, in hair restora tion, mesotherapy utilises agents like dutasteride and minoxidil to foster scalp health and combat hair loss. By synthesising current literature, this review underscores mesotherapy's potential in optimising skin health and addressing various dermatological chal lenges, including melasma, acne scarring, and different forms of alopecia.

Keywords: Mesotherapy; Skin Rejuvenation; Hair Loss; Alopecia.

References

1. Tang Z., et al. “Current application of mesotherapy in pattern hair loss_ a systematic review”. Journal of Cosmetic Dermatology10 (2022): 1-11.
2. Mysore V. “Mesotherapy in management of hair loss-is it of any use”. International Journal of Trichology1 (2010): 45-46.
3. Mammucari M., et al. “Mesotherapy: from historical notes to scientific evidence and future prospects”. The Scientific World Journal (2020).
4. Aditya K Gupta., et al. “Systematic review of mesotherapy: a novel avenue for the treatment of hair loss”. Journal of Dermatological Treatment 34 (2023): 1.
5. Kerscher M., et al. “Rejuvenating Influence of a Stabilized Hyaluronic Acid-Based Gel of Non Animal Origin on Facial Skin Aging”. Dermatologic Surgery 34 (2008): 720-726.
6. Mekawy K., et al. “Micro-needling versus fractional carbon dioxide laser for delivery of tranexamic acid in the treatment of melasma: a split-face study”. Journal of Cosmetic Dermatology2 (2021): 460-465.
7. Kong SH., et al. “Treatment of Melasma with Pulsed-Dye Laser and 1,064-nm Q-Switched Nd:YAG Laser: A Split-Face Study”. Annals of Dermatology1 (2018): 1-7.
8. Mammucari M., et al. “Mesotherapy, definition, rationale and clinical role: a consensus report from the Italian Society of Mesotherapy”. European Review for Medical and Pharmacological Sciences6 (2011): 682-694.
9. Mammucari M., et al. “What is mesotherapy? Recommendations from an international consensus”. Trends in Medicine (2014): 1-10.
10. Mammucari M., et al. “Intradermal therapy recommendations for standardization in localized pain management by the Italian Society of Mesotherapy”. Minerva Medicine (2019).
11. Herz-Ruelas ME., et al. “E#cacy of intralesional and oral dutasteride in the treatment of androgenetic alopecia: a systematic review”. Skin Appendage Disorder6 (2020): 338-345.
12. Abdallah M., et al. “Mesotherapy using dutasteride- containing solution in male pattern hair loss: a controlled pilot study”. Pan Arab League of Dermatology 20 (2009): 137-145.
13. Moftah N., et al. “Mesotherapy using dutasteride- containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation”. Journal of the European Academy of Dermatology and Venereology 6 (2013): 686-693.
14. Saceda-Corralo D., et al. “Mesotherapy with dutasteride in the treatment of androgenetic alopecia”. International Journal of Trichology3 (2017): 143-145.
15. DoNascimento IJB., et al. “Ectoforalminoxidilfor alopecia: systematic review”. International Journal of Trichology4 (2020): 147-155.
16. Sung CT., et al. “Thee#cacyoftopicalminoxidil for non-scarring alopecia: a systematic review”. Journal of Drugs Dermatology 18 (2019): 155-160.
17. Uzel BPC., et al. “Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: a randomized, placebo-controlled trial”. Dermatology Therapy 34 (2021): e14622.
18. Azam MH and Morsi HM. “Comparative study between 2%minoxidil topical spray vs. Intradermal injection (mesotherapy) for treatment of androgenetic alopecia in female patients: a controlled, 4-month randomized trial”. Egyptian Dermatology Online 6 (2010): 5.
19. Anitua E., et al. “The effect of plasma rich in growth factors on pattern hair loss: a pilot study”. Dermatology Surgery5 (2017): 658-670.
20. Kieb M., et al. “Platelet-Rich plasma powder: a new preparation method for the standardization of growth factor concentrations”. The American Journal of Sports Medicine 4 (2017): 954-960.
21. Álvarez X., et al. “Microscopic and histologic evaluation of the regenera®️ method for the treatment of androgenetic alopecia in a small number of cases”. International Journal of Medical Research and Health Sciences 2 (2017): 19-22.
22. El Samahy MH., et al. “Lyophilized growth factor intralesional injection in female pattern hair loss: a clinical and trichoscopic study”. Dermatology Therapy 34 (2021): e14867.
23. Müller Ramos P., et al. “Female pattern hair loss: therapeutic update”. Anais Brasileiros de Dermatologia (2023): S0365-0596:00053-00053.
24. Carloni R., et al. “Is there a therapeutic effect of botulinum toxin on scalp alopecia? Physiopathology and reported cases: a systematic review of the literature”. Journal of Plastic, Reconstructive and Aesthetic Surgery 12 (2020): 2210-2216.
25. Nassar A., et al. “Efficacy of botulinum toxin a injection in the treatment of androgenic alopecia: a comparative controlled study”. Journal of Cosmetic Dermatology10 (2022): 4261-4268.
26. Khattab FM., et al. “Recent modalities in treatment of telogen effluvium: comparative study”. Dermatology Therapy 35 (2022): e15720.
27. Krefft-Trzciniecka K., et al. “Androgenetic alopecia: a systematic review”. Cells 12 (2023): 951.
28. Gentile P and Garcovich S. “Systematic review of platelet-rich plasma use in androgenetic alopecia compared with minoxidil®️, finasteride®️, and adult stem cell-based therapy.” International Journal of Molecular Sciences 21 (2020): 2702.
29. Gajjar P., et al. “Comparative study between mesotherapy and topical 5% minoxidil by dermoscopic evaluation for androgenic alopecia in male: a randomized controlled trial”. International Journal of Trichology2 (2019): 58-67.
30. Shome D., et al. “Evaluation of efficacy of intradermal injection therapy vs derma roller application for administration of QR678 neo®️ hair regrowth formulation for the treatment of androgenetic alopecia —a prospective study”. Journal of Cosmetic Dermatology10 (2021): 3299-3307.
31. Dhurat R., et al. “A randomized evaluator blinded study of effect of microneedling in androgenic alopecia: A pilot study”. International Journal of Trichology 5 (2013): 611.
32. Dhurat R and Mathapati S. “Response to microneedling treatment in men with androgenetic alopecia who failed to respond to conventional therapy”. International Journal of Dermatology 60 (2015): 260-263.
33. Farid CI and Abdelmaksoud RA. “Platelet-rich plasma microneedling versus 5% topical minoxidil in the treatment of patterned hair loss”. Journal of the Egyptian Womenʼs Dermatologic Society 13 13 (2016): 29-36.
34. Chandrashekar B., et al. “Alopecia areata-successful outcome with microneedling and triamcinolone acetonide”. Journal of Cutaneous and Aesthetic Surgery 7 (2014): 63-64.
35. Jager C., et al. “Bioactive Reagents Used in Mesotherapy for Skin Rejuvenation in Vivo Induce Diverse Physiological Processes in Human Skin Fibroblasts in vitro—A Pilot Study”. Experimental Dermatology 21 (2011): 70-80.
36. Latha P and Vandana KR. “Mesotherapy—A Review”. International Journal of Advanced Pharmaceutics 1 (2011): 19-29.
37. Iorizzo M., et al. “Bio rejuvenation: Theory and Practice”. Clinics in Dermatology 26 (2008): 177-181.
38. Kerscher M., et al. “Rejuvenating Influence of a Stabilized Hyaluronic Acid-Based Gel of Non Animal Origin on Facial Skin Aging”. Dermatologic Surgery 34 (2008): 720-726.
39. Grand-Vincent A., et al. “Clinical assessment of a mesotherapy formulation for skin rejuvenation in healthy volunteers”. Journal of Cosmetic Dermatology4 (2007): 291-305.
40. Dessy LA., et al. “Randomized Prospective Study on the Efficacy of a New Revitalizing Filler Composed of Hyaluronic Acid”. Giornale Italiano di Dermatologia e Venereologia 143 (2008): 161-165.
41. Geesin JC., et al. “Regulation of Collagen Synthesis in Human Dermal Fibroblasts by the Sodium and Magnesium Salts of Ascorbyl-2-Phosphate”. Skin Pharmacology 6 (1993): 65-71.
42. Lin JY., et al. “UV Photoprotection by Combination Topical Antioxidants Vitamin C and Vitamin E”. Journal of the American Academy of Dermatology 48 (2008): 866-874.
43. Savoia A., et al. “A New Minimally Invasive Mesotherapy Technique for Facial Rejuvenation”. Dermatology and Therapy 3 (2013): 83-93.
44. Myllyharju J. “Prolyl 4-Hydroxylases, the Key Enzymes of Collagen Biosynthesis”. Matrix Biology 22 (2003): 15-24.
45. Nusgens BV., et al. “Topically Applied Vitamin C Enhances the mRNA Level of Collagens I and III, Their Processing Enzymes and Tissue Inhibitor of Matrix Metalloproteinase 1 in the Human Dermis”. Journal of Investigative Dermatology 116 (2001): 853-859.
46. Mohamed M., et al. “Microneedling with glutathione versus microneedling alone in treatment of facial melasma: split-face comparative study”. Journal of Cosmetic Dermatology (2023).
47. Mc Kesey J., et al. “Melasma treatment: an evidence-based review”. American Journal of Clinical Dermatology 2 (2020): 173-225.
48. Mekawy K., et al. “Micro-needling versus fractional carbon dioxide laser for delivery of tranexamic acid in the treatment of melasma: a split-face study”. Journal of Cosmetic Dermatology2 (2021): 460-465.
49. Kumawat K., et al. “Comparative study of efficacy of intradermal tranexamic acid microinjections versus intradermal glutathione microinjections for treatment of facial melasma”. Pigment International1 (2022): 46.
50. Singh A and Yadav S. “Microneedling: Advances and widening horizons”. Indian Dermatology Online Journal4 (2016): 244-254.
51. Nair PA and Arora TH. “Microneedling using dermaroller: A means of collagen induction therapy”. GMJ 69 (2014): 24-27.
52. Majid I., et al. “Microneedling and its applications in dermatology”. In Prime 7.4 (2014): 44-49.

Citation

Citation: Mohammed Al Abadie., et al. “Mesotherapy Applications in Dermatology". Acta Scientific Dental Sciences 7.1 (2025): 23-28.

Copyright

Copyright: © 2025 Mohammed Al Abadie., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.